Demise of CS and Compliance Officer
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Supha Pharmachem Ltd has informed BSE about the untimely death of its Company Secretary and Compliance Officer, Mr. Kapil Goplani (ICSI Membership No. A51763), who passed away on 13th January 2026. The company became aware of the demise only on 14th February 2026, when informed by his family, as he had been on leave for the previous two months. Mr. Goplani had been serving as CS and Compliance Officer since 1st June 2025, and the company has stated it is in the process of appointing a replacement.
This is a compassionate disclosure rather than a business-changing event. Investors should note that the company currently lacks a Compliance Officer, which is a regulatory requirement under SEBI's LODR rules, so timely appointment of a replacement will be important to avoid any compliance lapses. No direct impact on stock price or operations is expected from the disclosure itself.